News

Excellence in exporting honored for World Trade Day - Lifeloc Technologies & Terumo BCT

Wednesday, May 16, 2012

DENVER ¬— Wednesday, May 16, 2012 —The Colorado Office of Economic Development and International Trade (OEDIT) today announced the 2012 Governor’s Award for Excellence in Exporting.  The award has been given annually for more than 40 years and honors Colorado companies that demonstrate a commitment to international trade.  OEDIT’s Executive Director Ken Lund will present the awards to this year’s winners on May 17 at the 2012 World Trade Day event luncheon.  World Trade Day 2012 is being held at the Infinity Park, 4400 East Kentucky Avenue, Denver.   

CBSA Applauds Third Annual Gold Lab Symposium

Monday, May 14, 2012

Colorado BioScience Association Applauds Organizers of the Third Annual
Gold Lab Symposium at the University of Colorado
 

BCBR: Biotechs abuzz over high court ruling

Monday, May 14, 2012

Drug-patent decisions could affect millions in research funding
by Beth Potter 

E.I. Medical Imaging Awarded ISO 9001:2008 Certification

Saturday, May 12, 2012

LOVELAND, Colorado, E.I. Medical Imaging (EIMI), a worldwide leader in portable ultrasound systems for veterinary use announced today they have received ISO 9001:2008 Certification.  

Terumo BCT to Invest in State-of-the-Art Facilities in the U.S. and Vietnam

Thursday, May 10, 2012

Terumo BCT to Invest in State-of-the-Art Facilities in the U.S. and Vietnam
Facilities expansion will help serve the growing global demand for blood and cellular therapy products 

Nature: Drug-making plant blooms - featuring Ventria

Tuesday, May 08, 2012

Drug-making plant blooms
Approval of a ‘biologic’ manufactured in plant cells may pave the way for similar products.
BY AMY MAXMEN

It was midnight when an anxious Ari Zimran finally got the phone call for which he had been waiting. The news couldn’t have been better: the drug he had worked on for nearly a decade had just been approved by the US Food and Drug Administration (FDA). 

Clovis Oncology Announces First Quarter 2012 Operating Results

Tuesday, May 08, 2012

BOULDER, Colo.--()--Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for the first quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.  

Brad Ross Named Transaction Services Partner at Hein & Associates

Tuesday, May 08, 2012

May 8, 2012 — Mr. Ross serves as Hein’s Transaction Services Leader, consulting with both corporate and private equity clients on transactions ranging from $1M to several billion dollars in deal value. Brad’s expertise extends to buy- and sell-side diligence, as well as lender services projects.  

GRIFF/SMC WINS TWO GOLD KEY AWARDS

Monday, May 07, 2012

GRIFF/SMC WINS BEST CREATIVE, BEST STRATEGY AND TWO GOLD KEY AWARDS FROM BUSINESS MARKETING ASSOCIATION. 

R&D Team of Acertara Acoustic Laboratories Awarded Three New Patents

Monday, May 07, 2012

LONGMONT, CO May 7th, 2012. Acertara Acoustic Laboratories, the world’s only independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement and testing laboratory, announces that its research and development team has been awarded three new United States patents in as many weeks. US patents 8,159,900, 8,164,976, and 8,169,853, authored by John Timms, James Gessert, Matthew Fitzgibbons, and G. Wayne Moore are related to novel technology designed to validate the performance of diagnostic ultrasound systems. The R&D team members of Acertara have been awarded more than 30 United States patents.